Stoke Therapeutics, Inc. - STOK
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jun 05, 2026 | — | A | A | 17,786.0 | 0.0 | 0.0 | 17,786.0 | View | |
| Jun 05, 2026 | — | A | A | 17,786.0 | 0.0 | 0.0 | 17,786.0 | View | |
| Jun 05, 2026 | — | A | A | 17,786.0 | 0.0 | 0.0 | 17,786.0 | View | |
| Jun 05, 2026 | — | A | A | 17,786.0 | 0.0 | 0.0 | 17,786.0 | View | |
| Jun 05, 2026 | — | A | A | 17,786.0 | 0.0 | 0.0 | 17,786.0 | View | |
| Jun 05, 2026 | — | A | A | 17,786.0 | 0.0 | 0.0 | 17,786.0 | View | |
| Jun 05, 2026 | — | A | A | 17,786.0 | 0.0 | 0.0 | 17,786.0 | View | |
| Jun 03, 2026 | CHIEF MEDICAL OFFICER | S | D | 1,795.0 | 30.58 | 54,891.1 | 34,826.0 | View | |
| May 05, 2026 | CHIEF MEDICAL OFFICER | S | D | 2,243.0 | 32.79 | 73,547.97 | 36,621.0 | View | |
| Apr 07, 2026 | — | A | A | 30,782.0 | 0.0 | 0.0 | 30,782.0 | View | |
| Apr 03, 2026 | CHIEF MEDICAL OFFICER | S | D | 1,838.0 | 32.66 | 60,029.08 | 38,864.0 | View | |
| Mar 24, 2026 | GENERAL COUNSEL & CORP SEC | S | D | 601.0 | 34.4079 | 20,679.15 | 19,543.0 | View | |
| Mar 24, 2026 | GENERAL COUNSEL & CORP SEC | S | D | 8,692.0 | 33.6354 | 292,358.9 | 20,144.0 | View | |
| Mar 19, 2026 | Chief Patient Officer | S | D | 30.0 | 32.85 | 985.5 | 10,276.0 | View | |
| Mar 19, 2026 | Chief Patient Officer | S | D | 139.0 | 31.7888 | 4,418.64 | 10,306.0 | View | |
| Mar 19, 2026 | Chief Patient Officer | S | D | 1,762.0 | 31.2838 | 55,122.06 | 10,445.0 | View | |
| Mar 19, 2026 | Chief Patient Officer | S | D | 748.0 | 33.3754 | 24,964.8 | 12,207.0 | View | |
| Mar 19, 2026 | Chief Patient Officer | S | D | 1,033.0 | 32.7394 | 33,819.8 | 12,955.0 | View | |
| Mar 19, 2026 | Chief Financial Officer | S | D | 37.0 | 32.85 | 1,215.45 | 10,172.0 | View | |
| Mar 19, 2026 | Chief Financial Officer | S | D | 172.0 | 31.7888 | 5,467.67 | 10,209.0 | View | |
| Mar 19, 2026 | Chief Financial Officer | S | D | 2,173.0 | 31.2838 | 67,979.7 | 10,381.0 | View | |
| Mar 19, 2026 | Chief Financial Officer | S | D | 922.0 | 33.3754 | 30,772.12 | 12,554.0 | View | |
| Mar 19, 2026 | Chief Financial Officer | S | D | 1,274.0 | 32.7394 | 41,710.0 | 13,476.0 | View | |
| Mar 19, 2026 | CHIEF MEDICAL OFFICER | M | D | 1,365.0 | 0.0 | 0.0 | 83,035.0 | View | |
| Mar 19, 2026 | CHIEF MEDICAL OFFICER | S | D | 1,461.0 | 29.99 | 43,815.39 | 40,702.0 | View | |
| Mar 19, 2026 | CHIEF MEDICAL OFFICER | M | A | 1,365.0 | 2.19 | 2,989.35 | 42,163.0 | View | |
| Mar 19, 2026 | CHIEF MEDICAL OFFICER | S | D | 103.0 | 32.85 | 3,383.55 | 40,798.0 | View | |
| Mar 19, 2026 | CHIEF MEDICAL OFFICER | S | D | 483.0 | 31.7888 | 15,353.99 | 40,901.0 | View | |
| Mar 19, 2026 | CHIEF MEDICAL OFFICER | S | D | 6,100.0 | 31.2838 | 190,831.18 | 41,384.0 | View | |
| Mar 19, 2026 | CHIEF MEDICAL OFFICER | S | D | 2,587.0 | 33.3754 | 86,342.16 | 47,484.0 | View | |
| Mar 19, 2026 | CHIEF MEDICAL OFFICER | S | D | 3,577.0 | 32.7394 | 117,108.83 | 50,071.0 | View | |
| Mar 19, 2026 | GENERAL COUNSEL & CORP SEC | S | D | 72.0 | 32.85 | 2,365.2 | 28,836.0 | View | |
| Mar 19, 2026 | GENERAL COUNSEL & CORP SEC | S | D | 334.0 | 31.7888 | 10,617.46 | 28,908.0 | View | |
| Mar 19, 2026 | GENERAL COUNSEL & CORP SEC | S | D | 4,222.0 | 31.2838 | 132,080.2 | 29,242.0 | View | |
| Mar 19, 2026 | GENERAL COUNSEL & CORP SEC | S | D | 1,791.0 | 33.3754 | 59,775.34 | 33,464.0 | View | |
| Mar 19, 2026 | GENERAL COUNSEL & CORP SEC | S | D | 2,476.0 | 32.7394 | 81,062.75 | 35,255.0 | View | |
| Mar 17, 2026 | Chief Patient Officer | M | D | 10,000.0 | 0.0 | 0.0 | 30,000.0 | View | |
| Mar 17, 2026 | Chief Patient Officer | M | A | 10,000.0 | 0.0 | 0.0 | 13,988.0 | View | |
| Mar 17, 2026 | GENERAL COUNSEL & CORP SEC | M | D | 12,000.0 | 0.0 | 0.0 | 36,000.0 | View | |
| Mar 17, 2026 | GENERAL COUNSEL & CORP SEC | M | D | 6,000.0 | 0.0 | 0.0 | 12,000.0 | View | |
| Mar 17, 2026 | GENERAL COUNSEL & CORP SEC | M | D | 7,475.0 | 0.0 | 0.0 | 7,475.0 | View | |
| Mar 17, 2026 | GENERAL COUNSEL & CORP SEC | M | A | 12,000.0 | 0.0 | 0.0 | 37,731.0 | View | |
| Mar 17, 2026 | GENERAL COUNSEL & CORP SEC | M | A | 6,000.0 | 0.0 | 0.0 | 25,731.0 | View | |
| Mar 17, 2026 | GENERAL COUNSEL & CORP SEC | M | A | 7,475.0 | 0.0 | 0.0 | 19,731.0 | View | |
| Mar 17, 2026 | — | M | D | 26,250.0 | 0.0 | 0.0 | 52,500.0 | View | |
| Mar 17, 2026 | — | M | D | 35,500.0 | 0.0 | 0.0 | 35,500.0 | View | |
| Mar 17, 2026 | — | M | A | 26,250.0 | 0.0 | 0.0 | 110,874.0 | View | |
| Mar 17, 2026 | — | M | A | 35,500.0 | 0.0 | 0.0 | 84,624.0 | View | |
| Mar 17, 2026 | CHIEF MEDICAL OFFICER | M | D | 10,750.0 | 0.0 | 0.0 | 32,250.0 | View | |
| Mar 17, 2026 | CHIEF MEDICAL OFFICER | M | D | 10,000.0 | 0.0 | 0.0 | 20,000.0 | View | |
| Mar 17, 2026 | CHIEF MEDICAL OFFICER | M | D | 13,100.0 | 0.0 | 0.0 | 13,100.0 | View | |
| Mar 17, 2026 | CHIEF MEDICAL OFFICER | M | A | 10,750.0 | 0.0 | 0.0 | 53,648.0 | View | |
| Mar 17, 2026 | CHIEF MEDICAL OFFICER | M | A | 10,000.0 | 0.0 | 0.0 | 42,898.0 | View | |
| Mar 17, 2026 | CHIEF MEDICAL OFFICER | M | A | 13,100.0 | 0.0 | 0.0 | 32,898.0 | View | |
| Mar 17, 2026 | Chief Financial Officer | M | D | 14,750.0 | 0.0 | 0.0 | 44,250.0 | View | |
| Mar 17, 2026 | Chief Financial Officer | M | A | 14,750.0 | 0.0 | 0.0 | 14,750.0 | View | |
| Mar 17, 2026 | — | S | D | 605.0 | 36.8 | 22,264.0 | 4,237.0 | View | |
| Mar 12, 2026 | Interim Executive Chair | M | D | 3,955.0 | 0.0 | 0.0 | 118,696.0 | View | |
| Mar 12, 2026 | Interim Executive Chair | S | D | 4,355.0 | 40.0033 | 174,214.37 | 31,339.0 | View | |
| Mar 12, 2026 | Interim Executive Chair | M | A | 3,955.0 | 8.33 | 32,945.15 | 35,694.0 | View | |
| Mar 12, 2026 | — | S | D | 33,243.0 | 39.7366 | 1,320,963.79 | 283,302.0 | View | |
| Mar 04, 2026 | — | S | D | 7,229.0 | 39.6618 | 286,715.15 | 316,545.0 | View | |
| Feb 19, 2026 | GENERAL COUNSEL & CORP SEC | A | A | 35,000.0 | 0.0 | 0.0 | 35,000.0 | View | |
| Feb 19, 2026 | GENERAL COUNSEL & CORP SEC | A | A | 53,000.0 | 0.0 | 0.0 | 53,000.0 | View | |
| Feb 19, 2026 | Chief Patient Officer | A | A | 48,000.0 | 0.0 | 0.0 | 48,000.0 | View | |
| Feb 19, 2026 | Chief Patient Officer | A | A | 72,000.0 | 0.0 | 0.0 | 72,000.0 | View | |
| Feb 19, 2026 | Chief Financial Officer | A | A | 40,000.0 | 0.0 | 0.0 | 40,000.0 | View | |
| Feb 19, 2026 | Chief Financial Officer | A | A | 60,000.0 | 0.0 | 0.0 | 60,000.0 | View | |
| Feb 19, 2026 | Chief Executive Officer | A | A | 129,000.0 | 0.0 | 0.0 | 129,000.0 | View | |
| Feb 19, 2026 | Chief Executive Officer | A | A | 193,000.0 | 0.0 | 0.0 | 193,000.0 | View | |
| Feb 19, 2026 | CHIEF MEDICAL OFFICER | A | A | 40,000.0 | 0.0 | 0.0 | 40,000.0 | View | |
| Feb 19, 2026 | CHIEF MEDICAL OFFICER | A | A | 60,000.0 | 0.0 | 0.0 | 60,000.0 | View | |
| Jan 05, 2026 | — | M | D | 1,211.0 | 0.0 | 0.0 | 0.0 | View | |
| Jan 05, 2026 | — | M | A | 1,211.0 | 0.0 | 0.0 | 4,842.0 | View | |
| Dec 10, 2025 | GENERAL COUNSEL & CORP SEC | S | D | 2,678.0 | 32.6128 | 87,337.08 | 11,831.0 | View | |
| Dec 10, 2025 | GENERAL COUNSEL & CORP SEC | S | D | 1,300.0 | 31.5956 | 41,074.28 | 14,509.0 | View | |
| Dec 10, 2025 | — | S | D | 1,331.0 | 33.1041 | 44,061.56 | 49,124.0 | View | |
| Dec 10, 2025 | — | S | D | 8,274.0 | 32.52 | 269,070.48 | 50,455.0 | View | |
| Dec 10, 2025 | — | S | D | 3,825.0 | 31.4387 | 120,253.03 | 58,729.0 | View |